A 6-month, subject-masked, randomized controlled study to assess efficacy of dexamethasone as an adjunct to bevacizumab compared with bevacizumab alone in the treatment of patients with macular edema due to central or branch retinal vein occlusion
Raj K Maturi,1,2 Vincent Chen,3 Dan Raghinaru,3 Laurie Bleau,1 Michael W Stewart4 1Midwest Eye Institute, Indianapolis, IN, USA; 2Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, IN, USA; 3Jaeb Center for Health Research, Tampa, FL, USA; 4Department of Ophthalmolog...
Saved in:
Main Authors: | Maturi RK, Chen V, Raghinaru D, Bleau L, Stewart MW |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/cb6e9feb11294968a43238ada656744c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusion: 12-month results
by: Thapa R, et al.
Published: (2012) -
Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results
by: Demir M, et al.
Published: (2011) -
Comparison of single injection and three monthly injections of intravitreal bevacizumab for macular edema associated with branch retinal vein occlusion
by: Ito Y, et al.
Published: (2015) -
The comparison of intravitreal triamcinolone and bevacizumab in patients with macular edema secondary to branch retinal vein occlusion
by: Gokce G, et al.
Published: (2014) -
Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab
by: Yalamanchi S, et al.
Published: (2011)